Title:
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254
Document type:
Zeitschriftenaufsatz
Author(s):
Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gartland, Martin; Joshi, Samit R; Lataillade, Max
Journal title:
Clinical Infectious Diseases
Year:
2022
Journal volume:
75
Journal issue:
5
Pages contribution:
786-794
Fulltext / DOI:
doi:10.1093/cid/ciab1065
Publisher:
Oxford University Press (OUP)
E-ISSN:
1058-48381537-6591
Date of publication:
06.01.2022
BibTeX